Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
Vedolizumab is a monoclonal antibody medicine developed by Takeda Pharmaceuticals for the treatment of ulcerative colitis and Crohn’s disease.
The report details the trend, potential and market size of Entyvio (vedolizumab) Drug market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Entyvio (vedolizumab) Drugmarket, defines the market attractiveness level of Entyvio (vedolizumab) Drug market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Entyvio (vedolizumab) Drug industry, describes the types of Entyvio (vedolizumab) Drug market, the applications of major players and the market size, and deeply analyzes the current situation of the global Entyvio (vedolizumab) Drug market and the development prospects and opportunities of Entyvio (vedolizumab) Drug industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Entyvio (vedolizumab) Drug market in Chapter 13.
By Player:
Takeda
By Type:
Type 1
Type 2
Type 3
By End-User:
Ulcerative Colitis
Crohn's Disease
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Entyvio (vedolizumab) Drug Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Entyvio (vedolizumab) Drug Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Entyvio (vedolizumab) Drug Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Entyvio (vedolizumab) Drug Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Entyvio (vedolizumab) Drug Market Analysis and Outlook to 2022
-
7.1 Global Entyvio (vedolizumab) Drug Consumption (2017-2022)
-
7.2 United States Entyvio (vedolizumab) Drug Consumption (2017-2022)
-
7.3 Europe Entyvio (vedolizumab) Drug Consumption (2017-2022)
-
7.4 China Entyvio (vedolizumab) Drug Consumption (2017-2022)
-
7.5 Japan Entyvio (vedolizumab) Drug Consumption (2017-2022)
-
7.6 India Entyvio (vedolizumab) Drug Consumption (2017-2022)
-
7.7 South Korea Entyvio (vedolizumab) Drug Consumption (2017-2022)
8 Region and Country-wise Entyvio (vedolizumab) Drug Market Analysis and Outlook to 2028
-
8.1 Global Entyvio (vedolizumab) Drug Consumption Forecast (2022-2028)
-
8.2 United States Entyvio (vedolizumab) Drug Consumption Forecast (2022-2028)
-
8.3 Europe Entyvio (vedolizumab) Drug Consumption Forecast (2022-2028)
-
8.4 China Entyvio (vedolizumab) Drug Consumption Forecast (2022-2028)
-
8.5 Japan Entyvio (vedolizumab) Drug Consumption Forecast (2022-2028)
-
8.6 India Entyvio (vedolizumab) Drug Consumption Forecast (2022-2028)
-
8.7 South Korea Entyvio (vedolizumab) Drug Consumption Forecast (2022-2028)
9 Global Entyvio (vedolizumab) Drug Market Outlook by Types and Applications to 2022
-
9.1 Global Entyvio (vedolizumab) Drug Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Type 1 Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Type 2 Consumption and Growth Rate (2017-2022)
-
9.1.3 Global Type 3 Consumption and Growth Rate (2017-2022)
-
9.2 Global Entyvio (vedolizumab) Drug Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Ulcerative Colitis Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Crohn's Disease Consumption and Growth Rate (2017-2022)
10 Global Entyvio (vedolizumab) Drug Market Outlook by Types and Applications to 2028
-
10.1 Global Entyvio (vedolizumab) Drug Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Type 1 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global Type 3 Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Entyvio (vedolizumab) Drug Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Ulcerative Colitis Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Crohn's Disease Consumption Forecast and Growth Rate (2022-2028)
11 Global Entyvio (vedolizumab) Drug Import and Export Analysis (Top 5 Countries)
-
11.1 Global Entyvio (vedolizumab) Drug Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Entyvio (vedolizumab) Drug Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Entyvio (vedolizumab) Drug Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Entyvio (vedolizumab) Drug Market Competitive Analysis
-
14.1 Takeda
-
14.1.1 Takeda Company Details
-
14.1.2 Takeda Entyvio (vedolizumab) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Takeda Entyvio (vedolizumab) Drug Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Entyvio (vedolizumab) Drug
-
Figure Entyvio (vedolizumab) Drug Picture
-
Table Global Entyvio (vedolizumab) Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Entyvio (vedolizumab) Drug Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Entyvio (vedolizumab) Drug Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Entyvio (vedolizumab) Drug Consumption by Country (2017-2022)
-
Figure United States Entyvio (vedolizumab) Drug Consumption and Growth Rate (2017-2022)
-
Table Europe Entyvio (vedolizumab) Drug Consumption and Growth Rate (2017-2022)
-
Figure China Entyvio (vedolizumab) Drug Consumption and Growth Rate (2017-2022)
-
Figure Japan Entyvio (vedolizumab) Drug Consumption and Growth Rate (2017-2022)
-
Figure India Entyvio (vedolizumab) Drug Consumption and Growth Rate (2017-2022)
-
Figure South Korea Entyvio (vedolizumab) Drug Consumption and Growth Rate (2017-2022)
-
Figure Global Entyvio (vedolizumab) Drug Consumption Forecast by Country (2022-2028)
-
Figure United States Entyvio (vedolizumab) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Entyvio (vedolizumab) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Entyvio (vedolizumab) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Entyvio (vedolizumab) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Entyvio (vedolizumab) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Entyvio (vedolizumab) Drug Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 1 Consumption and Growth Rate (2017-2022)
-
Figure Global Type 2 Consumption and Growth Rate (2017-2022)
-
Figure Global Type 3 Consumption and Growth Rate (2017-2022)
-
Figure Global Ulcerative Colitis Consumption and Growth Rate (2017-2022)
-
Figure Global Crohn's Disease Consumption and Growth Rate (2017-2022)
-
Figure Global Type 1 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 2 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Type 3 Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Ulcerative Colitis Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Crohn's Disease Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Entyvio (vedolizumab) Drug Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Entyvio (vedolizumab) Drug Export by Region (Top 5 Countries) (2017-2028)
-
Table Takeda (Foundation Year, Company Profile and etc.)
-
Table Takeda Entyvio (vedolizumab) Drug Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Entyvio (vedolizumab) Drug Product and Service
-
